|
1
|
Lehninger AL, Nelson DL and Cox MM:
Principles of Biochemistry. 2nd edition. Worth; New York: 1993
|
|
2
|
Widmer J, Fassihi KS, Schlichter SC,
Wheeler KS, Crute BE, King N, Nutile-Mcmenemy N, Noll WW, Daniel S,
Ha J, Kim KH and Witters LA: Identification of a second human
acetyl-CoA carboxylase gene. Biochem J. 316:915–922.
1996.PubMed/NCBI
|
|
3
|
Medina V, Edmonds B, Young GP, James R,
Appleton S and Zalewski PD: Induction of caspase-3 protease
activity and apoptosis by butyrate and trichostatin A (inhibitors
of histone deacetylase): dependence on protein synthesis and
synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer
Res. 57:3697–3707. 1997.
|
|
4
|
Richon VM, Emiliani S, Verdin E, Webb Y,
Breslow R, Rifkind RA and Marks PA: A class of hybrid polar
inducers of transformed cell differentiation inhibits histone
deacetylases. Proc Natl Acad Sci USA. 95:3003–3007. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang J, Saunthararajah Y, Redner RL and
Liu JM: Inhibitors of histone deacetylase relieve ETO-mediated
repression and induce differentiation of AML1-ETO leukemia cells.
Cancer Res. 59:2766–2769. 1999.PubMed/NCBI
|
|
6
|
Butler LM, Agus DB, Scher HI, Higgins B,
Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA and Richon
VM: Suberoylanilide hydroxamic acid, an inhibitor of histone
deacetylase, suppresses the growth of prostate cancer cells in
vitro and in vivo. Cancer Res. 60:5165–5170. 2000.PubMed/NCBI
|
|
7
|
Roy S, Packman K, Jeffrey R and Tenniswood
M: Histone deacetylase inhibitors differentially stabilize
acetylated p53 and induce cell cycle arrest or apoptosis in
prostate cancer cells. Cell Death Differ. 12:482–491. 2005.
View Article : Google Scholar
|
|
8
|
Heerdt BG, Houston MA, Anthony GM and
Augenlicht LH: Initiation of growth arrest and apoptosis of MCF-7
mammary carcinoma cells by tributyrin, a triglyceride analogue of
the shortchain fatty acid butyrate, is associated with
mitochondrial activity. Cancer Res. 59:1584–1591. 1999.PubMed/NCBI
|
|
9
|
Benjamin D and Jost JP: Reversal of
methylation-mediated repression with short-chain fatty acids:
evidence for an additional mechanism to histone deacetylation.
Nucleic Acids Res. 29:3603–3610. 2001. View Article : Google Scholar
|
|
10
|
Lee MG, Wynder C, Bochar DA, Hakimi MA,
Cooch N and Shiekhattar R: Functional interplay between histone
demethylase and deacetylase enzymes. Mol Cell Biol. 26:6395–6402.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duan H, Heckman CA and Boxer LM: Histone
deacetylase inhibitors down-regulate bcl-2 expression and induce
apoptosis in lymphomas. Mol Cell Biol. 25:1608–1619. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Earel JK Jr, VanOosten RL and Griffith TS:
Histone deacetylase inhibitors modulate the sensitivity of tumor
necrosis factor-related apoptosis-inducing ligand-resistant bladder
tumor cells. Cancer Res. 66:499–507. 2006. View Article : Google Scholar
|
|
13
|
Neuzil J, Swettenham E and Gellert N:
Sensitization of mesothelioma to TRAIL apoptosis by inhibition of
histone deacetylase: role of Bcl-xL down-regulation. Biochem
Biophys Res Commun. 314:186–191. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi YH: Induction of apoptosis by
trichostatin A, a histone deacetylase inhibitor, is associated with
inhibition of cyclooxygenase-2 activity in human non-small cell
lung cancer cells. Int J Oncol. 27:473–479. 2005.PubMed/NCBI
|
|
15
|
Donadelli M, Costanzo C, Faggioli L,
Scupoli MT, Moore PS, Bassi C, Scarpa A and Palmieri M:
Trichostatin A, an inhibitor of histone deacetylases, strongly
suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog.
38:59–69. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wetzel M, Premkumar DR, Arnold B and
Pollack IF: Effect of trichostatin A, a histone deacetylase
inhibitor, on glioma proliferation in vitro by inducing cell cycle
arrest and apoptosis. J Neurosurg. 103:549–556. 2005.PubMed/NCBI
|
|
17
|
Archer SY, Johnson J, Kim HJ, Ma Q, Mou H,
Daesety V, Meng S and Hodin RA: The histone deacetylase inhibitor
butyrate down-regulates cyclin B1 gene expression via a
p21/WAF-1-dependent mechanism in human colon cancer cells. Am J
Physiol Gastrointest Liver Physiol. 289:G696–G703. 2005.
|
|
18
|
Sakimura R, Tanaka K, Nakatani F,
Matsunobu T, Li X, Hanada M, Okada T, Nakamura T, Matsumoto Y and
Iwamoto Y: Antitumor effects of histone deacetylase inhibitor on
Ewing’s family tumors. Int J Cancer. 116:784–792. 2005.
|
|
19
|
Terui T, Murakami K, Takimoto R, Takahashi
M, Takada K, Murakami T, Minami S, Matsunaga T, Takayama T, Kato J
and Niitsu Y: Induction of PIG3 and NOXA through acetylation of p53
at 320 and 373 lysine residues as a mechanism for apoptotic cell
death by histone deacetylase inhibitors. Cancer Res. 63:8948–8954.
2003.PubMed/NCBI
|
|
20
|
Sathyanarayana UG, Padar A, Tockman MS,
Lam S, Shivapurkar N and Gazdar AF: Epigenetic down-regulation of
death-associated protein kinase in lung cancers. Clin Cancer Res.
9:3034–3041. 2003.PubMed/NCBI
|
|
21
|
Zhang X, Yashiro M, Ren J and Hirakawa K:
Histone deacetylase inhibitor, trichostatin A, increases the
chemosensitivity of anticancer drugs in gastric cancer cell lines.
Oncol Rep. 16:563–568. 2006.PubMed/NCBI
|
|
22
|
Inbal B, Cohen O, Polak-Charcon S,
Kopolovic J, Vadai E and Eisenbach L: DAP-kinase links the control
of apoptosis to metastasis. Nature. 390:180–184. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chopin V, Toillon RA, Jouy N and Le
Bourhis X: Sodium butyrate induces p53-independent Fas-mediated
apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol.
135:79–86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu X, Guo ZS, Marcu MG, Neckers L, Nguyen
DM, Chen GA and Schrump DS: Modulation of p53, ErbB1, ErbB2 and
Raf-1 expression in lung cancer cells by depsipeptide FR901228. J
Natl Cancer Inst. 94:504–513. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Blagosklonny MV, Robey R, Sackett DL, Du
L, Traganos F, Darzynkiewicz Z, Fojo T and Bates SE: Histone
deacetylase inhibitors all induce p21 but differentially cause
tubulin acetylation, mitotic arrest and cytotoxicity. Mol Cancer
Ther. 1:937–941. 2002.
|
|
26
|
Xia H, Nho RS, Kahm J, Kleidon J and Henke
CA: Focal adhesion kinase is upstream of phosphatidylinositol
3-kinase/akt in regulating fibroblast survival in response to
contraction of type I collagen matrices via a beta 1 integrin
viability signaling pathway. J Biol Chem. 279:33024–33034. 2004.
View Article : Google Scholar
|
